Reduction of Intrapartum Fever With Intravenous Acetaminophen

Status unconfirmed · Phase 2

Conditions studied: Fever, Oxidative Stress

In brief

The investigators plan to administer acetaminophen (Tylenol) for the treatment of fever in laboring patients by either an oral or intravenous (IV) route. The investigators want to see if the maternal fever will decrease faster with the IV or the oral dose. The investigators also want to look at other outcomes such as the cesarean section rate, the rate of neonatal intensive care unit admissions in both groups.

Key facts

Study ID

NCT02625454

Run by

Richmond University Medical Center

People needed

168

Starts

2016-12-01

Expected to finish

2019-10-01

Last updated by the study team

2019-07-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients at Richmond University Medical Center that entered active labor (spontaneous or induced) and developed a systemic fever of greater than 38 degrees Celsius.

You may not qualify if…

• Exclusion Criteria: Infants delivered before 36 week gestation, stillbirths, congenital fetal anomalies, scheduled cesarean deliveries, and acetaminophen allergy

Where it is running

• Richmond University Medical Center — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.